These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 22160410)

  • 1. Coronary pseudoaneurysm in a non-polymer drug-eluting stent: a rare entity.
    Kapoor A; Batra A; Kumar S; Pandey S; Agarwal SK; Sinha N
    Asian Cardiovasc Thorac Ann; 2011 Dec; 19(6):407-10. PubMed ID: 22160410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enlarged coronary artery pseudoaneurysm after drug-eluting stent implantation.
    Hori D; Noguchi K; Nomura Y; Tanaka H
    Asian Cardiovasc Thorac Ann; 2013 Oct; 21(5):608-11. PubMed ID: 24570568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infected pseudoaneurysm involving a drug-eluting stent.
    Furtado AD; Bhat SP; Peer SM; Chikkatur R
    Interact Cardiovasc Thorac Surg; 2011 Apr; 12(4):636-7. PubMed ID: 21228044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary artery aneurysms after drug-eluting stent implantation.
    Koniari I; Koletti B; Apostolakis E
    Interact Cardiovasc Thorac Surg; 2011 Apr; 12(4):638. PubMed ID: 21429891
    [No Abstract]   [Full Text] [Related]  

  • 5. Transient coronary aneurysm formation after Nevo™ stent implantation versus persistent coronary aneurysm after Cypher Select™ stent implantation.
    Christiansen EH; Lassen JF; Jensen LO
    J Invasive Cardiol; 2011 Jul; 23(7):E158-60. PubMed ID: 21725130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous resolution of coronary artery pseudoaneurysm consequent to percutaneous intervention with paclitaxel-eluting stent.
    Chen D; Chang R; Ho AT; Frivold G; Foster G
    Tex Heart Inst J; 2008; 35(2):189-91; discussion 192. PubMed ID: 18612455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the pathology different between drug-eluting stent and bare stent related coronary aneurysms?
    Arslan Y; Hasdemir H; Kehlibar T; Yilmaz M
    Interact Cardiovasc Thorac Surg; 2011 Apr; 12(4):638. PubMed ID: 21429892
    [No Abstract]   [Full Text] [Related]  

  • 8. Multiple coronary artery aneurysm formation one year and four years after sirolimus-eluting coronary stent implantation.
    Ovünç K; Yorgun H; Ozer N
    Cardiovasc Revasc Med; 2009; 10(4):252-4. PubMed ID: 19815173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Covered-stent treatment of coronary aneurysm after drug-eluting stent placement: case report and literature review.
    Bajaj S; Parikh R; Hamdan A; Bikkina M
    Tex Heart Inst J; 2010; 37(4):449-54. PubMed ID: 20844620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Very late stent thrombosis associated with multiple stent fractures and peri-stent aneurysm formation after sirolimus-eluting stent implantation.
    Lee SE; John SH; Lim JH; Rhew JY
    Circ J; 2008 Jul; 72(7):1201-4. PubMed ID: 18577836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary artery aneurysms associated with a Paclitaxel coated stent.
    Wang D; Gunalingam B
    Heart Lung Circ; 2008 Feb; 17(1):66-9. PubMed ID: 17419098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incomplete arterial healing 8 years after the implantation of sirolimus-eluting stent. In vivo visualization by optical coherence tomography.
    Bouki KP; Sakkali EK; Apostolou TS
    Catheter Cardiovasc Interv; 2012 Mar; 79(4):625-7. PubMed ID: 21735524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crush stenting with paclitaxel-eluting or sirolimus-eluting stents for the treatment of coronary bifurcation lesions.
    Chen S; Zhang J; Ye F; Zhu Z; Lin S; Tian N; Liu Z; Fang W; Chen Y; Sun X; Kwan TW
    Angiology; 2008; 59(4):475-83. PubMed ID: 18388098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term clinical and economic analysis of the Endeavor zotarolimus-eluting stent versus the cypher sirolimus-eluting stent: 3-year results from the ENDEAVOR III trial (Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions).
    Eisenstein EL; Leon MB; Kandzari DE; Mauri L; Edwards R; Kong DF; Cowper PA; Anstrom KJ;
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1199-207. PubMed ID: 20129546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiographic outcomes with biodegradable polymer and permanent polymer drug-eluting stents.
    Kufner S; Massberg S; Dommasch M; Byrne RA; Tiroch K; Ranftl S; Fusaro M; Schömig A; Kastrati A; Mehilli J;
    Catheter Cardiovasc Interv; 2011 Aug; 78(2):161-6. PubMed ID: 21400652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of biodegradable polymer-coated sirolimus-eluting stents in "real-world" practice: 18-month clinical and 9-month angiographic outcomes.
    Han Y; Jing Q; Xu B; Yang L; Liu H; Shang X; Jiang T; Li Z; Zhang H; Li H; Qiu J; Liu Y; Li Y; Chen X; Gao R;
    JACC Cardiovasc Interv; 2009 Apr; 2(4):303-9. PubMed ID: 19463441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late-term clinical outcomes with zotarolimus- and sirolimus-eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions).
    Kandzari DE; Mauri L; Popma JJ; Turco MA; Gurbel PA; Fitzgerald PJ; Leon MB
    JACC Cardiovasc Interv; 2011 May; 4(5):543-50. PubMed ID: 21596327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late safety, efficacy, and cost-effectiveness of a zotarolimus-eluting stent compared with a paclitaxel-eluting stent in patients with de novo coronary lesions: 2-year follow-up from the ENDEAVOR IV trial (Randomized, Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Taxus Paclitaxel-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions).
    Leon MB; Kandzari DE; Eisenstein EL; Anstrom KJ; Mauri L; Cutlip DE; Nikolsky E; O'Shaughnessy C; Overlie PA; Kirtane AJ; McLaurin BT; Solomon SL; Douglas JS; Popma JJ;
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1208-18. PubMed ID: 20129547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NEVO™: a new generation of sirolimus-eluting coronary stent.
    Falotico R; Parker T; Grishaber R; Price S; Cohen SA; Rogers C
    EuroIntervention; 2009 Dec; 5 Suppl F():F88-93. PubMed ID: 22100684
    [No Abstract]   [Full Text] [Related]  

  • 20. Coronary artery aneurysm occurring very late after drug-eluting stent implantation.
    Okamura K; Suematsu Y; Morizumi S; Kawata M
    Interact Cardiovasc Thorac Surg; 2014 Dec; 19(6):1068-70. PubMed ID: 25164132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.